Rotator cuff tendinopathy Musculoskeletal Diseases Rotator cuff tendinopathy
Conditions
Interventions
The active supplements used in this trial were MaxEPA supplements (Seven Seas Ltd, Hull, UK). They are gelatine coated capsules, oval in shape and brown tan in colour, containing 170mg EPA, 115mg DHA,
Sponsors
Guy's and St Thomas' NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The study aimed to recruit men and women aged 18 to 80 years, who were referred for physiotherapy to one of four physiotherapy departments with a diagnosis of unilateral RC tendinopathy. 1. Unilateral shoulder pain of more than 3 months duration (anterior &/or antero-lateral 2. Pain produced or increased during flexion and/or abduction of the symptomatic shoulder 3. Failure of conservative management (manual therapy, exercises, injections, electrotherapy NSAIDS) 4. At least 4 of the following: 4.1 Positive Neer’s impingement sign 4.2 Positive Hawkins & Kennedy test 4.3 Pain & weakness reproduced on full & empty can test 4.4 Pain & weakness on resisted shoulder external rotation 4.5 Pain on palpation over greater tuberosity of humerus
Exclusion criteria
Exclusion criteria: 1. Outside age range of 18-80 years 2. Known allergy to fish or fish products 3. Unwilling to take fish oils 4. Currently taking high dose fish oils (over 1g daily). 5. Diabetes 6. Pregnancy or breast feeding 7. Reproduction of shoulder symptoms during active cervical spine movements 8. Post traumatic onset of symptoms 9. Radiographic or clinical evidence of shoulder instability (sulcus, anterior/posterior draw, relocation test, apprehension test)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Oxford shoulder score questionnaire was used at baseline, 2 months, 3 months, 6 months and 12 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Numerical rating score for pain 2. Shoulder Pain and Disability Index (SPADI) 3. Patient specific functional score (PSFS): a questionnaire used to quantify activity limitation and measure functional outcome in areas chosen by the patient specifically 4. EuroQol D5-3L (EQ-D5-3L) health questionnaire: a measure of health related quality of life 5. Short Form (SF)-36 6. Global perception of change 7. Range of glenohumeral range of motion (flexion/abduction/internal and external rotation, hand behind back) 8. Shoulder strength (shoulder flexion/abduction/internal and external rotation and biceps strength). All taken at baseline, 2 months, 3 months, 6 months and 12 months. | — |
Countries
United Kingdom
Outcome results
None listed